Related Experiment Videos

[Hypertension and arteriosclerosis]

A C Pessina1, P Pauletto, G P Rossi

  • 1Cattedra di Medicina Interna, Università degli Studi di Padova.

Annali Italiani Di Medicina Interna : Organo Ufficiale Della Societa Italiana Di Medicina Interna
|July 1, 1992
PubMed

Insights

Arterial hypertension contributes to atherosclerosis through hemodynamic changes and humoral factors. Emerging evidence highlights hyperinsulinemia and potential antiatherogenic effects of antihypertensive drugs.

Area of Science:

  • Cardiovascular Medicine
  • Pathophysiology

Context:

  • Arterial hypertension is a primary risk factor for atherosclerosis.
  • Hemodynamic factors like elevated blood pressure and turbulent flow contribute but don't fully explain the link.
  • Humoral factors, including catecholamines, renin-angiotensin-aldosterone system, serotonin, endothelin, platelets, and growth factors, play significant roles.

Purpose:

  • To explore the multifaceted mechanisms linking arterial hypertension to atherosclerosis.
  • To investigate the role of humoral factors and hyperinsulinemia in this relationship.
  • To review recent findings on the antiatherogenic potential of antihypertensive agents.

Summary:

  • Hypertension accelerates atherosclerosis via elevated blood pressure, increased wave velocity, and flow turbulence.
  • Humoral factors (catecholamines, RAAS, serotonin, endothelin, platelets, growth factors) are crucial.
  • Hyperinsulinemia, often co-occurring with hypercholesterolemia and hypertriglyceridemia in hypertensive patients, is increasingly recognized.

Impact:

  • Understanding these mechanisms can lead to targeted therapies for atherosclerosis in hypertensive individuals.
  • Recent findings suggest some antihypertensive agents may possess antiatherogenic properties, slowing lesion progression.
  • This research highlights the complex interplay between hypertension, metabolic factors, and cardiovascular disease progression.

Related Concept Videos